Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Oxford Nanopore trims medium-term guidance, shares slide
(Sharecast News) - Shares in Oxford Nanopore Technologies fell sharply in morning trading on Monday, after the FTSE 250 firm lowered its medium-term guidance. The loss-making company - a specialist in nanopore-based molecular sensing technology - posted revenues for the year to 31 December of £223.9m, a 22.2% jump, or 24.2% on a constant currency basis. Adjusted losses, meanwhile, narrowed to £86.7m from £117.9m.
Oxford Nanopore reiterated plans to reach adjusted earnings before interest, tax, depreciation and amortisation breakeven in the 2027 full-year, and cash breakeven by 2028.
However, constant currency revenue growth was forecast to be between 21% and 25% in both 2026 and 2027. It had previously forecast revenue growth of between 25% and 30% for 2027.
As at 0930 GMT, the stock had tumbled 12% at 116.6p.
The results coincided with Francis Van Parys taking over as chief executive. He is replacing co-founder Gordon Sanghera, who is stepping down after leading the company for more than two decades.
Van Parys said he was joining at an "important stage" in Oxford Nanopore's development. "The company is delivering strong growth and making progress on its path to profitability, underpinned by its differentiated sensing platform and expanding global customer base," he added.
Sanghera said: "Leading Oxford Nanopore for more than two decades has been an extraordinary privilege."
Berenberg said: "Despite a difficult macro environment, the company delivered a strong performance in 2025.
"Despite ongoing macro uncertainty, Oxford Nanopore still expects to reach EBITDA and cash breakeven. However, it has adjusted the assumptions in its medium-term guidance, now expecting lower revenue growth, leading us to lower our revenue forecasts, but higher gross margins and lower operating cost growth.
"Regardless of these changes, we continue to see substantial upside on the share price."
Berenberg trimmed its price target to 230p from 250p but reiterated its 'buy' rating.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
